Q1 2023 Acorda Therapeutics Inc Earnings Call Transcript

May 11, 2023 / 08:30PM GMT
Operator

Welcome to Acorda Therapeutics First Quarter 2023 Financial and Business Update. (Operator Instructions) Please be advised that this call is being recorded at the company's request.

I will now introduce your host for today's call, Tierney Saccavino at Acorda. Tierney, please go ahead.

Tierney Saccavino - Acorda Therapeutics, Inc. - EVP of Corporate Communications

Thank you, Terry, and good afternoon, everyone. Before we begin, let me remind everyone that our presentation will contain forward-looking statements. Detailed disclosures can be found in our SEC filings, which are public, and we encourage you to refer to those filings. Today, during Q&A, we will take questions that some investors have written in when they registered for the call.

I'll now pass the call over to our CEO, Ron Cohen. Ron?

Ron Cohen - Acorda Therapeutics, Inc. - Founder, CEO, President & Director

Thanks, Tierney. Welcome, everyone. We will start with INBRIJA. INBRIJA U.S. net revenue for the first quarter of 2023 was $5

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot